发病概况■我国是HCC高发地区，HCC患者数约占全球总数的55%■85%-95%的HCC患者由肝硬化逐渐演变而来■在中国的HCC患者中，合并门静脉高压症患者占15%-■门静脉高压症严重影响HCC的治疗与预后[1]Huang JH,Gao F,Gu YK,et al.Combined treatment of carciinoma with partial splenic embolization and trachemoembolization ]World Gastroenterol,00714593-637[2]Boyer TD,Haskal ZJ,American Association for the Study of Liver Diseases.The role of transjugular intrahepatiin the management of portal hypetension update 2009[J].Heptology,2010,51(1):306[3]de Franchis R:Baveno VI Faculty.Expanding consensus in portal hypertension:Report of the Baveno VI Conrisk and individualizing care for portal hypertension [J].J Hepatol,2015,63(3)743-752
